HLA-G 3′UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer

Polymorphisms in drug-metabolizing enzymes might not completely explain inter-individual differences in toxicity profiles of patients with colorectal cancer (CRC) that receive folinic acid/5-fluorouracil/oxaliplatin (FOLFOX4). Recent data indicate that the immune system could contribute to FOLFOX4 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Garziera, Marica, Virdone, Saverio, De Mattia, Elena, Scarabel, Lucia, Cecchin, Erika, Polesel, Jerry, D’Andrea, Mario, Pella, Nicoletta, Buonadonna, Angela, Favaretto, Adolfo, Toffoli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535859/
https://www.ncbi.nlm.nih.gov/pubmed/28653974
http://dx.doi.org/10.3390/ijms18071366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535859/
https://www.ncbi.nlm.nih.gov/pubmed/28653974
http://dx.doi.org/10.3390/ijms18071366

Ejemplares similares